Hoth Therapeutics Stock Price Prediction

HOTH Stock  USD 0.81  0.04  4.71%   
As of 14th of December 2024, the relative strength index (RSI) of Hoth Therapeutics' share price is approaching 47. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Hoth Therapeutics, making its price go up or down.

Oversold Vs Overbought

47

 
Oversold
 
Overbought
The successful prediction of Hoth Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Hoth Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Hoth Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.32)
EPS Estimate Current Year
(1.54)
EPS Estimate Next Year
(0.87)
Wall Street Target Price
4.5
EPS Estimate Current Quarter
(0.34)
Using Hoth Therapeutics hype-based prediction, you can estimate the value of Hoth Therapeutics from the perspective of Hoth Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Hoth Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Hoth because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Hoth Therapeutics after-hype prediction price

    
  USD 0.81  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Hoth Therapeutics Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Hoth Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.091.895.96
Details
1 Analysts
Consensus
LowTargetHigh
4.785.255.83
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.47-0.39-0.29
Details

Hoth Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Hoth Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Hoth Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Hoth Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Hoth Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Hoth Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Hoth Therapeutics' historical news coverage. Hoth Therapeutics' after-hype downside and upside margins for the prediction period are 0.04 and 4.88, respectively. We have considered Hoth Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.81
0.81
After-hype Price
4.88
Upside
Hoth Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Hoth Therapeutics is based on 3 months time horizon.

Hoth Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Hoth Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hoth Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Hoth Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.26 
4.07
 0.00  
  0.09 
3 Events / Month
12 Events / Month
In about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.81
0.81
0.00 
40,700  
Notes

Hoth Therapeutics Hype Timeline

Hoth Therapeutics is currently traded for 0.81. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.09. Hoth is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.26%. %. The volatility of related hype on Hoth Therapeutics is about 1182.42%, with the expected price after the next announcement by competition of 0.72. The company has price-to-book (P/B) ratio of 0.75. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hoth Therapeutics recorded a loss per share of 1.27. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 26th of October 2022. Given the investment horizon of 90 days the next anticipated press release will be in about 3 days.
Check out Hoth Therapeutics Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.

Hoth Therapeutics Related Hype Analysis

Having access to credible news sources related to Hoth Therapeutics' direct competition is more important than ever and may enhance your ability to predict Hoth Therapeutics' future price movements. Getting to know how Hoth Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Hoth Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ATXIAvenue Therapeutics 0.01 6 per month 0.00 (0.16) 6.03 (6.67) 24.31 
REVBRevelation Biosciences 0.09 5 per month 0.00 (0.13) 8.97 (7.84) 73.15 
NRBONeurobo Pharmaceuticals 0.05 7 per month 0.00 (0.21) 6.76 (7.34) 24.34 
VRAXVirax Biolabs Group(0.81)4 per month 0.00 (0.06) 9.65 (11.20) 61.28 
ZURAZura Bio Limited 0.14 10 per month 0.00 (0.12) 7.95 (9.71) 26.70 
PHIOPhio Pharmaceuticals Corp(0.20)6 per month 5.69  0.02  11.78 (9.23) 36.22 
SONNSonnet Biotherapeutics Holdings(6.25)8 per month 0.00 (0.23) 13.38 (15.35) 37.58 
ATNF180 Life Sciences(0.23)7 per month 6.95  0.07  14.14 (11.29) 358.73 
CDIOCardio Diagnostics Holdings 0.07 5 per month 6.69  0.21  40.74 (12.90) 74.39 
BXRXBaudax Bio 0.53 2 per month 0.00 (0.03) 8.24 (15.31) 141.24 
TCONTRACON Pharmaceuticals 0.00 0 per month 0.00 (0.17) 19.59 (17.77) 52.05 
ADTXAditxt Inc(0.03)9 per month 0.00 (0.53) 6.06 (28.15) 42.69 
QNRXQuoin Pharmaceuticals Ltd(0.03)11 per month 5.35  0.03  9.21 (9.59) 74.46 
ALLRAllarity Therapeutics 0.02 10 per month 0.00 (0.25) 5.80 (10.48) 41.48 
KRBPKiromic Biopharma(0.24)3 per month 0.00 (0.03) 12.04 (10.96) 65.24 
BDRXBiodexa Pharmaceticals 0.40 7 per month 0.00 (0.06) 13.30 (19.70) 97.78 
BWVBWV(0.01)2 per month 2.98  0.03  4.26 (4.72) 68.28 
HILSHillstream Biopharma 0.03 3 per month 0.00 (0.06) 8.33 (7.89) 113.15 
KPRXKiora Pharmaceuticals(0.08)6 per month 0.00 (0.04) 5.95 (5.41) 19.67 

Hoth Therapeutics Additional Predictive Modules

Most predictive techniques to examine Hoth price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Hoth using various technical indicators. When you analyze Hoth charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Hoth Therapeutics Predictive Indicators

The successful prediction of Hoth Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Hoth Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Hoth Therapeutics based on analysis of Hoth Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Hoth Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Hoth Therapeutics's related companies.
 2023 2024 (projected)
PB Ratio0.560.53
Capex To Depreciation184.64175.4

Story Coverage note for Hoth Therapeutics

The number of cover stories for Hoth Therapeutics depends on current market conditions and Hoth Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Hoth Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Hoth Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Hoth Therapeutics Short Properties

Hoth Therapeutics' future price predictability will typically decrease when Hoth Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Hoth Therapeutics often depends not only on the future outlook of the potential Hoth Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hoth Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding3.4 M
Cash And Short Term Investments9.3 M

Complementary Tools for Hoth Stock analysis

When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
CEOs Directory
Screen CEOs from public companies around the world